YOLFTbeta
Medy-Tox Inc

Medy-Tox Inc

086900 · KQ · Healthcare / Biotechnology

71,500.00KRW+1600.00 (+2.29%)

Price History

Full chart

Market Stats

Previous Close69,900.00
Open70,000.00
Day Range69,900.00 – 73,700.00
52-Week Range65,600.00 – 141,100.00
Volume33.30K
Market Cap432.70B
P/E (TTM)0.00
Forward P/E20.66
Dividend Yield0.00%
Beta0.41
50-Day Avg70,776.00
200-Day Avg97,497.00

About

Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; and Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method. It also exports its products to approximately 60 countries, including Japan, Brazil, and internationally. Medy-Tox Inc. was founded in 2000 and is headquartered in Cheongju, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Hyun-Ho Jung
  • Employees703
  • Headquarters78, Gak-ri 1-gil, Cheongju, South Korea, Korea
  • Websitehttps://www.medytox.com

Leadership

  • Mr. Hyun-Ho JungChief Executive Officer & Chairman · b. 1962
  • Mr. Ki-Hyuk YangHead of Laboratory, Senior MD & Director · b. 1969
  • Mr. Seung-Bum ParkHead of Production Division & Director · b. 1969
  • Mr. Shin Hyo JinExecutive Director
  • Mr. Kim Hack WooExecutive Director

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue39.14B75.89B88.51B133.26B181.24B205.44B205.90B140.83B184.87B195.10B221.12B228.62B247.29B
Growth (%)-+93.89%+16.62%+50.56%+36.01%+13.36%+0.22%-31.60%+31.27%+5.53%+13.34%+3.39%+8.17%
Cost of Revenue3.66B5.54B14.17B24.08B34.59B54.24B69.53B66.49B79.02B68.69B87.25B89.59B104.01B
Gross Profit-68.76B74.34B109.18B146.65B151.21B136.37B74.34B105.85B126.41B133.87B139.03B143.28B
Gross Margin-90.61%83.99%81.93%80.91%73.60%66.23%52.79%57.26%64.79%60.54%60.81%57.94%
Operating Expense-18.81B23.53B34.00B59.66B67.29B113.45B115.79B-24.50B85.56B109.61B120.21B126.27B
Operating Income16.76B49.96B50.80B75.17B86.99B83.92B22.92B-41.45B130.35B40.85B24.26B18.82B17.01B
Operating Margin42.81%65.83%57.40%56.41%48.00%40.85%11.13%-29.43%70.51%20.94%10.97%8.23%6.88%
EBITDA---------66.94B33.56B39.18B27.30B
EBITDA Margin---------34.31%15.18%17.14%11.04%
Net Income14.30B43.63B42.29B59.23B70.11B69.96B26.21B-29.58B94.15B37.01B9.76B16.95B16.59B
Net Income Margin36.54%57.49%47.79%44.45%38.68%34.05%12.73%-21.00%50.93%18.97%4.41%7.42%6.71%
R&D5.56B7.61B5.00B8.27B19.06B19.08B-32.54B23.27B23.32B25.13B29.82B29.19B
R&D as % of Total Revenue14.20%10.02%5.65%6.21%10.52%9.29%-23.11%12.59%11.96%11.37%13.04%11.80%
Interest Expense00000004.18B4.78B2.31B2.33B1.73B649.39M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.97%2.59%1.19%1.06%0.76%0.26%

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets79.41B168.51B203.55B324.03B380.95B395.01B421.53B467.76B577.70B596.29B611.62B615.16B581.76B
Total Liabilities18.73B86.92B90.07B176.35B189.29B142.43B162.38B226.37B178.22B168.24B137.14B144.38B127.47B
Total Equity60.68B81.59B113.48B147.68B191.65B252.59B259.15B241.40B399.48B428.04B469.46B466.48B451.84B
Cash4.41B5.06B27.17B15.80B26.38B19.25B20.01B43.99B71.77B21.19M33.25B46.17B48.89B
Total Debt---101.51B74.95B-102.05B146.85B-----
Net Debt-------102.55B60.24B99.43B47.83B33.14B25.73B

Cash Flow

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow16.60B105.38B22.37B54.10B56.55B55.07B33.70B27.93B19.97B26.20B13.52B36.89B61.41B
Investing Cash Flow--83.74B-7.49B-114.26B-38.19B-16.09B-28.39B-52.02B-27.78B-36.12B13.25B-646.92M-
Financing Cash Flow--20.87B6.81B49.18B-7.37B-46.03B-4.48B50.72B34.80B-40.39B-13.54B-24.05B-
Capital Expenditure16.55B16.64B33.81B144.67B38.04B8.50B21.02B41.14B17.51B9.90B37.47B18.72B34.22B
Free Cash Flow--------16.38B-1.38B1.10B-23.95B17.83B27.19B
Dividends Paid2.72B8.11B8.54B9.60B11.12B12.14B4.33B5.54B8.04B8.04B8.42B8.42B8.92B
FCF to OCF--------58.65%-6.90%4.19%-177.11%48.34%44.27%
Dividend Paid to FCF--------33.82%-583.74%732.05%-35.17%47.24%32.81%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Aug 14, 2014Nov 14, 2014Feb 9, 2015May 16, 2015Aug 18, 2015Nov 13, 2015Feb 24, 2016May 13, 2016Aug 16, 2016Nov 14, 2016Feb 23, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 14, 2018May 14, 2018Aug 14, 2018Nov 13, 2018Mar 12, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 4, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 23, 2021May 17, 2021Aug 13, 2021Nov 14, 2021Mar 16, 2022May 16, 2022Aug 12, 2022Nov 14, 2022Mar 7, 2023May 15, 2023Aug 7, 2023Nov 8, 2023Mar 29, 2024May 10, 2024Aug 9, 2024Nov 6, 2024Mar 5, 2025May 12, 2025Aug 7, 2025Nov 10, 2025Mar 19, 2026May 15, 2026Aug 13, 2026
EPS Estimate----------------------------1939.782211.542153.012604.402524.732861.342401.793248.413631.353022.452547.542924.262638.802570.531412.941639.84509.66-236.70419.18672.10-815.42521.71308.44203.56-98.87824.26427.892622.22---1247.002255.002058.00-----814.27554.37729.09
EPS Actual235.27402.95331.78364.59324.95460.76351.02395.73168.80312.15196.53427.78479.53690.89597.35543.26364.11617.75534.23624.53987.551303.993316.141005.151303.051796.471600.361754.152008.752437.862234.302756.312608.043160.102046.213998.493861.822821.382279.092385.202213.561622.84478.88-160.30-919.12-918.26-8.64-2902.498629.485372.343268.03-2340.00639.053020.002102.86-75.07-79.821273.00-345.11-309.00-218.321695.08565.99451.35542.121192.831059.01-493.001193.00479.00
Surprise----------------------------3.56%10.23%3.78%5.83%3.30%10.44%-14.80%23.09%6.35%-6.65%-10.54%-18.43%-16.11%-36.87%-66.11%-109.78%-280.34%-287.94%-102.06%-531.85%1158.29%929.76%959.54%-1249.54%746.35%266.39%391.45%-102.86%----124.78%-109.68%-17.63%------160.54%115.20%-34.30%
Timing---------------------Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap432.70B
Enterprise Value511.94B
Trailing P/E0.00
Forward P/E20.66
Price / Sales1.72
Price / Book1.16
Revenue (TTM)251.08B
Gross Profit (TTM)154.99B
EBITDA37.14B
Profit Margin6.10%
Operating Margin6.94%
Return on Equity3.59%
Return on Assets1.85%
Shares Outstanding6.46M
Shares Float5.02M
Beta0.41
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio52.82%

Dividends

20261×
1200.00Oct 28, 2026
20251×
1200.00Sep 29, 2025
20241×
1100.00Sep 27, 2024
20231×
1100.00Sep 26, 2023
20221×
952.38Sep 29, 2022
20211×
1000.00Sep 29, 2021
20201×
863.84Sep 28, 2020
20191×
670.94Sep 27, 2019
20181×
732.83Sep 27, 2018
20172×
1139.95Dec 27, 2017651.40Sep 28, 2017
20162×
1058.53Dec 28, 2016569.98Sep 29, 2016
20152×
895.68Dec 29, 2015488.55Sep 25, 2015
20142×
814.25Dec 29, 2014407.13Sep 29, 2014
20131×
814.25Dec 27, 2013
20121×
407.13Dec 27, 2012
20111×
244.28Dec 28, 2011
20101×
244.28Dec 29, 2010

Stock Splits

  • Dec 28, 202221:20
  • Dec 29, 202121:20
  • Dec 29, 202021:20
  • Dec 27, 2019103:100
  • Dec 27, 2018103:100
  • Dec 29, 2009103:100